Digitally Enhanced Stepped-Care for Depression in Primary Care
Official title: Digitally Enhanced Stepped-Care for Depression in Primary Care: A Pilot Randomized Clinical Trial to Support Scalable Deployment and Commercialization
Run by Medical University of South Carolina · NCT07634705 · Data updated 2026-11-12
A small pilot study tests whether using a self-guided Moodivate app first, with a possible switch to teletherapy if needed, helps adults with depression in primary care more effectively than teletherapy alone or Moodivate alone.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Medical University of South Carolina Academic / other |
| Locations | 1 site (Charleston, South Carolina) |
| Status | Recruiting |
| Started | July 2, 2026 |
| Main results expected | June 2027 |
| Study ends | June 2027 |
| Registry record updated | July 9, 2026 |
| Trial ID | NCT07634705 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 and older with PHQ-9 scores of 10 or higher who own a smartphone, are willing to use Moodivate, and consent to telehealth depression treatment in South Carolina.
✕Probably not a fit
Individuals without smartphone access, non-English fluency, current psychosocial depression treatment, or active suicidal ideation may not benefit from this design.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot, three-arm randomized trial will enroll 40 adults with elevated depressive symptoms from MUSC primary care clinics in South Carolina. Participants are randomized 2:1:1 to: 1) a stepped-care approach starting with the Moodivate self-guided Behavioral Activation app and stepping to clinician-delivered telebehavioral therapy at week 2 based on engagement and early PHQ-9 change; 2) telebehavioral activation delivered via telehealth; or 3) Moodivate alone. Feasibility is defined by continued engagement after stepping or a minimum level of use and therapy sessions over 12 weeks, with secondary outcomes including change in PHQ-9 from baseline to week 12. Remote screening, electronic consent, and REDCap assessments will be used, with the study conducted across MUSC primary care sites in South Carolina. Primary care clinicians and digital tools are integrated to assess whether a digitally enhanced stepped-care model is workable in real-world settings.
Why it matters
Potential benefit: If successful, the approach could offer a more flexible, scalable way to reduce depressive symptoms in primary care using digital and telehealth options.
How similar studies have gone: Prior work has shown behavioral activation and digital health tools can reduce depressive symptoms, but this specific stepped-care combination in primary care is exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria:
* elevated depression symptoms (score of \>=10 on the PHQ-9)
* age \>=18 years
* owns an iOS or Android smartphone
* willing to use Moodivate
* willing to engage in telehealth depression treatment
* access to email or text messaging (for assessments)
* English fluency
Exclusion Criteria:
* current receipt of psychosocial depression treatment (e.g., individual or group therapy)
* current suicidal ideation, defined as a response \>=1 ("several days") on PHQ-9 item nine
* does not live in the state of South Carolina
Where it's running
-
Medical University of South Carolina
Charleston, South Carolina, United States Recruiting
Study contacts
- Principal investigator: Jennifer Dahne, PhD — Medical University of South Carolina
- Study coordinator: Noelle Natale
- Email: natalen@musc.edu
- Phone: 843-876-9457
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Smartphone-supported single-session psychotherapy for postpartum depression
A single online therapy session plus four weeks of app-based support is being tested to see if it reduces depressive symptoms in postpartum women compared with a waitlist.
-
Mindful Smartphone Use: A Mindfulness-Based Program for Teens with Sleep and Mood Challenges
This study tests Mindwire, a mindfulness-based program, to see if it helps teens with problematic phone use who also have depression or anxiety.
-
Tele-based wellbeing centres for women's mental health in Bangladesh
A randomized trial tests whether tele-counselling for depression and anxiety in Bangladeshi women is as effective as in-person counselling.
-
Remote monitoring for adults with depression using ThIA Suivi
This study tests whether adding the ThIA Suivi remote monitoring tool to usual psychiatric care helps adults with depression feel more improved after 3 months compared with standard care alone.
-
HBOT to see if it helps cognition and well‑being in first responders with prior brain injury
This study tests whether 40 hyperbaric oxygen therapy sessions can improve thinking skills and post-concussion symptoms in current or former first responders with a history of brain injury.
-
Focused ultrasound for mood and anxiety disorders
This study tests whether repeated low-intensity focused ultrasound using the ATTN201 device can help people with subsyndromal to moderate depression, anxiety, or OCD.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.